Clinically isolated syndromes with no further disease activity suggestive of multiple sclerosis at the age of population life expectancy

Multiple Sclerosis Journal

Volumn 20, Issue 4, 2014, Pages 496-500

  Novakova, L ^a   Skoog, B ^a   Runmarker, B ^a   Ekholm, S ^b   Winblad, S ^a   Lisovskaja, V ^c   Andersen, O ^a  

^a UNIVERSITY OF GOTHENBURG   (Sweden)

^b UNIVERSITY OF ROCHESTER   (United States)

^c CHALMERS UNIVERSITY OF TECHNOLOGY   (Sweden)

Author keywords

Clinically isolated syndrome; cohort; magnetic resonance imaging; multiple sclerosis; neuropsychology; optic neuritis

Indexed keywords

AGED; ARTICLE; CONTROLLED STUDY; DEMYELINATING DISEASE; DISEASE ACTIVITY; FEMALE; FOLLOW UP; HUMAN; INCIDENCE; LIFE EXPECTANCY; MAJOR CLINICAL STUDY; MALE; MULTIPLE SCLEROSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; PROGNOSIS; RELAPSE; VERY ELDERLY; COHORT ANALYSIS; NEUROPSYCHOLOGY; ONSET AGE; OPTIC NEURITIS; PREDICTION; SURVIVAL TIME;

CLINICALLY ISOLATED SYNDROME; COHORT; MAGNETIC RESONANCE IMAGING; MULTIPLE SCLEROSIS; NEUROPSYCHOLOGY; OPTIC NEURITIS;

ADOLESCENT; ADULT; AGE OF ONSET; CHILD; DEMYELINATING DISEASES; DISEASE PROGRESSION; FEMALE; FOLLOW-UP STUDIES; HUMANS; INCIDENCE; LIFE EXPECTANCY; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS; PROGNOSIS; RECURRENCE; YOUNG ADULT;

EID: 84896131365     PISSN: 13524585     EISSN: 14770970     Source Type: Journal    
DOI: 10.1177/1352458513496345     Document Type: Article

References (12)

1. Miller D, Barkhof F, Montalban X, et al. Clinically isolated syndromes suggestive of multiple sclerosis, part I: Natural history, pathogenesis, diagnosis, and prognosis. Lancet Neurol. 2005 ; 4: 281-288
2. Nilsson P, Larsson EM, Maly-Sundgren P, et al. Predicting the outcome of optic neuritis: Evaluation of risk factors after 30 years of follow-up. J Neurol. 2005 ; 252: 396-402
3. Multiple sclerosis risk after optic neuritis: Final optic neuritis treatment trial follow-up. Arch Neurol. 2008 ; 65: 727-732
4. Fisniku LK, Brex PA, Altmann DR, et al. Disability and T2 MRI lesions: A20-year follow-up of patients with relapse onset of multiple sclerosis. Brain. 2008 ; 131: 808-817
5. Skoog B, Runmarker B, Winblad S, et al. A representative cohort of patients with non-progressive multiple sclerosis at the age of normal life expectancy. Brain. 2012 ; 135: 900-911
6. Runmarker B, Andersen O. Prognostic factors in a multiple sclerosis incidence cohort with twenty-five years of follow-up. Brain. 1993 ; 116 (Pt 1). 117-134
7. Polman CH, Reingold SC, Banwell B, et al. Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria. Ann Neurol. 2011 ; 69: 292-302
8. Dobson R, Ramagopalan S, Giovannoni G. The effect of gender in clinically isolated syndrome (CIS): A meta-analysis. Mult Scler. 2012 ; 18: 600-604
9. Eriksson M, Andersen O, Runmarker B. Long-term follow up of patients with clinically isolated syndromes, relapsing-remitting and secondary progressive multiple sclerosis. Mult Scler. 2003 ; 9: 260-274
10. Kurland LT. The evolution of multiple sclerosis epidemiology. Ann Neurol. 1994 ; 36 (Suppl). S2-5
11. Kurtzke JF Multiple sclerosis, clinical and pathogenetic basis. Raine CS McFarland HF Tourtellotte WW, ed. London: Chapman and Hall Medical ; 1997: 91-139.
12. Collongues N, Cabre P, Marignier R, et al. A benign form of neuromyelitis optica: Does it exist?. Arch Neurol. 2011 ; 68: 918-924